September 3, 2019
Digitalization of clinical trials will soon become the norm for pharma industry. In the industry’s ongoing quest to bring new life-saving treatments to the world, telemedicine offers the potential to be an effective and a sustainable technology platform for improving the efficiency and quality of clinical trials. Most of the […]
July 31, 2019
Up to 60% of the global population will suffer from chronic diseases such as heart failure, stroke, diabetes, blood pressure etc., by 2030. Most of the prescriptions, Outpatient and Emergency room visits driven by patients suffering from chronic diseases. Given the exponential increase in demand for healthcare, technologies like telemedicine […]
July 24, 2019
Shifting demands, price and portfolio pressures are pushing pharma manufacturers to fast-track innovation Precision medicine is having a direct impact on manufacturing facilities from complexity and activity perspectives: Pharma companies are now forced to think in terms of manufacturing medicine for a few thousand patients instead of the traditional mass volume manufacturing. […]
April 22, 2019
The role of partnership in the pharmaceutical industry is ever increasing in realising the business goals. Our presentation provides a partnering scorecard for the year 2018. It also provides a pipeline gap analysis which is one of the key drivers for partnerships in pharmaceutical industry. The presentation also benchmarks the […]
March 6, 2019
Rare Disease Situation Analysis is aimed at providing a high level glimpse into the rare disease drug development and commercialization. Rare disease drug development has been an increasingly attractive proposition for biopharmaceutical companies.
May 25, 2018
This presentation takes the reader on an exciting journey, about the Science beneath the development of Oncology Nano Drug delivery systems. How the tumor mico and macro environments throws conspicuous challenges to the nanotech field? Furthermore, the presentation also gives a sneak view of Nanotherapeutics clinical landscape across development strategies and tumors.